These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1419749)

  • 1. Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis.
    Kristensen M; Deleuran B; Eedy DJ; Feldmann M; Breathnach SM; Brennan FM
    Br J Dermatol; 1992 Oct; 127(4):305-11. PubMed ID: 1419749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor.
    Kristensen M; Chu CQ; Eedy DJ; Feldmann M; Brennan FM; Breathnach SM
    Clin Exp Immunol; 1993 Nov; 94(2):354-62. PubMed ID: 8222328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis.
    Debets R; Hegmans JP; Croughs P; Troost RJ; Prins JB; Benner R; Prens EP
    J Immunol; 1997 Mar; 158(6):2955-63. PubMed ID: 9058835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor antagonist in normal and psoriatic epidermis.
    Hammerberg C; Arend WP; Fisher GJ; Chan LS; Berger AE; Haskill JS; Voorhees JJ; Cooper KD
    J Clin Invest; 1992 Aug; 90(2):571-83. PubMed ID: 1386612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 receptor antagonist blocks chemokine production in the mixed lymphocyte reaction.
    Lukacs NW; Kunkel SL; Burdick MD; Lincoln PM; Strieter RM
    Blood; 1993 Dec; 82(12):3668-74. PubMed ID: 8260704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-inflammatory cytokines.
    Funding AT; Johansen C; Kragballe K; Otkjaer K; Jensen UB; Madsen MW; Fjording MS; Finnemann J; Skak-Nielsen T; Paludan SR; Iversen L
    J Invest Dermatol; 2006 Aug; 126(8):1784-91. PubMed ID: 16543895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.
    Groves RW; Sherman L; Mizutani H; Dower SK; Kupper TS
    Am J Pathol; 1994 Nov; 145(5):1048-56. PubMed ID: 7977638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts.
    Krzesicki RF; Hatfield CA; Bienkowski MJ; McGuire JC; Winterrowd GE; Chapman DL; Berger AE; McEwan RN; Carter DB; Chosay JG
    J Immunol; 1993 May; 150(9):4008-18. PubMed ID: 8473746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2.
    Johansen C; Funding AT; Otkjaer K; Kragballe K; Jensen UB; Madsen M; Binderup L; Skak-Nielsen T; Fjording MS; Iversen L
    J Immunol; 2006 Feb; 176(3):1431-8. PubMed ID: 16424170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis.
    Anttila HS; Reitamo S; Erkko P; Ceska M; Moser B; Baggiolini M
    J Invest Dermatol; 1992 Jan; 98(1):96-101. PubMed ID: 1728643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA treatment.
    Oxholm A; Oxholm P; Staberg B; Bendtzen K
    Acta Derm Venereol; 1989; 69(3):195-9. PubMed ID: 2566221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas.
    Chensue SW; Warmington KS; Berger AE; Tracey DE
    Am J Pathol; 1992 Feb; 140(2):269-75. PubMed ID: 1531398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells.
    Sim TC; Hilsmeier KA; Reece LM; Grant JA; Alam R
    Am J Respir Cell Mol Biol; 1994 Oct; 11(4):473-9. PubMed ID: 7917315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1: a key inflammatory mediator in psoriasis?
    Mee JB; Cork MJ; di Giovine FS; Duff GW; Groves RW
    Cytokine; 2006 Jan; 33(2):72-8. PubMed ID: 16460958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis.
    Smith DR; Kunkel SL; Standiford TJ; Rolfe MW; Lynch JP; Arenberg DA; Wilke CA; Burdick MD; Martinez FJ; Hampton JN
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1965-73. PubMed ID: 7767546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood.
    DeForge LE; Tracey DE; Kenney JS; Remick DG
    Am J Pathol; 1992 May; 140(5):1045-54. PubMed ID: 1533750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.